Heng-Jian Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Heng-Jian Huang has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
He He
Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
9 shared publicationsMei Zhang
Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
5 shared publications- Zhenmei An
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China
5 shared publications - Li-Bo Liang
West China Hospital of Sichuan University, Chengdu, People's Republic of China,
4 shared publications - Shuang-Qing Li
Golden Card Hospital, West China Hospital, Sichuan University, Chengdu 610041, China
4 shared publications Yuping Zeng
Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
4 shared publications
Latest Publications
- 1 August 2022
- Published by Elsevier in Clinica Chimica Acta
- Vol. 534, 161-166
Biological variation of cardiovascular biochemical markers in patients with Type 2 Diabetes Mellitus
- 1 August 2022
- Published by Elsevier in Clinica Chimica Acta
- Vol. 534, 161-166
Biological variation of cardiovascular biochemical markers in patients with Type 2 Diabetes Mellitus
- 1 August 2021
- Published by Elsevier in Clinical Biochemistry
- Vol. 94, 42-47
Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia
- 1 August 2021
- Published by Elsevier in Clinical Biochemistry
- Vol. 94, 42-47
Clinical laboratory characteristics of patients with obstructive jaundice accompanied by dyslipidemia
- 1 March 2019
- Vol. 49 (2) , 218-223
The Association between Serum Uric Acid Levels and Insulin Resistance and Secretion in Prediabetes Mellitus: A Cross-Sectional Study
Background. We investigated the association between serum uric acid (SUA) levels and insulin secretion and resistance in prediabetes patients, which is currently unclear. Methods. Our study population consisted of 11,523 representative patients from northwest China. It was divided into three groups based on the results of an oral glucose tolerance test: the non-diabetes group (n=3234), the impaired glucose regulation (IGR, prediabetes) group (n=2886), and the type-2 diabetes mellitus group (n=5403). SUA and 2-hour insulin (2h-Ins) levels were measured, and homeostasis model assessment of insulin resistance (HOMA-IR) scores were computed. The association between SUA level and insulin secretion and resistance was assessed via multivariate regression analysis. Results. SUA and 2-hour insulin levels were highest in the IGR group in both men and women. After adjusting for multiple confounding risk factors, SUA levels significantly correlated with 2-hour insulin levels (odds ratio=1.700, 95% confidence interval=1.390, 2.080, P<0.001) and HOMA-IR scores (odds ratio=2.017, 95% confidence interval=1.671, 2.434, P<0.001) in the impaired glucose regulation (IGR) group. Conclusion. SUA was positively associated with hyperinsu-linemia and insulin resistance in prediabetes patients in the retrospective study and is thus a potential risk factor for these conditions.
- 1 March 2019
- Vol. 49 (2) , 218-223
The Association between Serum Uric Acid Levels and Insulin Resistance and Secretion in Prediabetes Mellitus: A Cross-Sectional Study
Background. We investigated the association between serum uric acid (SUA) levels and insulin secretion and resistance in prediabetes patients, which is currently unclear. Methods. Our study population consisted of 11,523 representative patients from northwest China. It was divided into three groups based on the results of an oral glucose tolerance test: the non-diabetes group (n=3234), the impaired glucose regulation (IGR, prediabetes) group (n=2886), and the type-2 diabetes mellitus group (n=5403). SUA and 2-hour insulin (2h-Ins) levels were measured, and homeostasis model assessment of insulin resistance (HOMA-IR) scores were computed. The association between SUA level and insulin secretion and resistance was assessed via multivariate regression analysis. Results. SUA and 2-hour insulin levels were highest in the IGR group in both men and women. After adjusting for multiple confounding risk factors, SUA levels significantly correlated with 2-hour insulin levels (odds ratio=1.700, 95% confidence interval=1.390, 2.080, P<0.001) and HOMA-IR scores (odds ratio=2.017, 95% confidence interval=1.671, 2.434, P<0.001) in the impaired glucose regulation (IGR) group. Conclusion. SUA was positively associated with hyperinsu-linemia and insulin resistance in prediabetes patients in the retrospective study and is thus a potential risk factor for these conditions.
- 8 February 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 492, 57-61
Practical application of the sigma-metric run size nomogram for multistage bracketed statistical quality control analysis of eight enzymes
- 8 February 2019
- Published by Elsevier in Clinica Chimica Acta
- Vol. 492, 57-61
Practical application of the sigma-metric run size nomogram for multistage bracketed statistical quality control analysis of eight enzymes
- Open Access
- 21 November 2018
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 33 (3) , e22715
Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
Background: Glycated hemoglobin (HbA1c) and glycated serum albumin (GSA) are used to evaluate the mean blood glucose levels. To ensure safe clinical application of HbA1c and GSA, reliable biological variation (BV) data are required. The aim of this research was to define the BV of HbA1c and GSA employing stringent rules.Methods: Blood samples were drawn from 19 healthy subjects (10 females, nine males) once per week for 5 weeks. All samples were analyzed using enzymatic method for GSA and HPLC for HbA1c. The data were assessed for outliers, normality and variance homogeneity, and coefficient of variation (by ANOVA) for BV. Sex‐stratified BV including within‐subject (CVI) and between‐subject (CVG) was defined for HbA1c and GSA.Results: The following estimates for BV values for CVI and CVG, respectively, were GSA: 1.23% and 4.67%, Alb: 0.75% and 3.18%, and HbA1c: 0.12% and 2.91%. The RCV of GSA was 3.61%, and HbA1c was 1.41%. And the II was 0.26 for GSA, and 0.07 for HbA1c, both of them less than 0.6. According to the 95% CI, the CVI of HbA1c was statistically different between females and males. And both the CVG of HbA1c and GSA were statistically different between females and males.Conclusion: All CVI and CVG estimates were lower than those reported in the online BV database. And there is a significant difference between males and females. Analytical performance specifications derived from BV of this research can be applied internationally.
- 21 November 2018
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 33 (3) , e22715
Open AccessEvaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
Background: Glycated hemoglobin (HbA1c) and glycated serum albumin (GSA) are used to evaluate the mean blood glucose levels. To ensure safe clinical application of HbA1c and GSA, reliable biological variation (BV) data are required. The aim of this research was to define the BV of HbA1c and GSA employing stringent rules.Methods: Blood samples were drawn from 19 healthy subjects (10 females, nine males) once per week for 5 weeks. All samples were analyzed using enzymatic method for GSA and HPLC for HbA1c. The data were assessed for outliers, normality and variance homogeneity, and coefficient of variation (by ANOVA) for BV. Sex‐stratified BV including within‐subject (CVI) and between‐subject (CVG) was defined for HbA1c and GSA.Results: The following estimates for BV values for CVI and CVG, respectively, were GSA: 1.23% and 4.67%, Alb: 0.75% and 3.18%, and HbA1c: 0.12% and 2.91%. The RCV of GSA was 3.61%, and HbA1c was 1.41%. And the II was 0.26 for GSA, and 0.07 for HbA1c, both of them less than 0.6. According to the 95% CI, the CVI of HbA1c was statistically different between females and males. And both the CVG of HbA1c and GSA were statistically different between females and males.Conclusion: All CVI and CVG estimates were lower than those reported in the online BV database. And there is a significant difference between males and females. Analytical performance specifications derived from BV of this research can be applied internationally.
- Open Access
- 4 April 2018
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 17 (1) , 70
The prevalence change of hyperlipidemia and hyperglycemia and the effectiveness of yearly physical examinations: an eight-year study in Southwest China
The aim of this study was to investigate the prevalence changes of hyperlipidemia and hyperglycemia from 2009 to 2016 and the effectiveness of yearly physical examinations to hyperlipidemia and hyperglycemia prevention in Chengdu. A total of 794 residents (499 males) who have undergone annual health check-ups for 8 consecutive years (from 2009 to 2016) in Chengdu, a city in southwest China were selected as the follow-up group, 7226 residents in 2009 and 75,068 residents in 2016 who underwent health examinations in the same hospital were chosen to be the contemporary control group. The concentration of fasting serum triglyceride(TG), total cholesterol(TC), low density lipoprotein cholesterol(LDL-C), high density lipoprotein cholesterol (HDL-C) and glucose were measured and compared among these groups. There was a clear rise in the prevalence of hypercholesterolemia and hyperglycemia from 2009 to 2016 (p < 0.05). The follow-up group didn’t show difference in levels of serum lipids and glucose compared with the general population after an 8-years’ consecutive physical examination (p > 0.05), the follow-up cohort in the 8th year exhibited significant increases in serum total cholesterol and glucose compared with the 1st year (p < 0.05). The prevalence of hypercholesterolemia and hyperglycemia were increased significantly from 2009 to 2016. Annual physical examination didn’t show a positive effect in the prevention of hypercholesterolemia and hyperglycemia. Health education should be improved to ensure the fulfillment of the preventive objective of yearly physical examination.
- 4 April 2018
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 17 (1) , 70
Open AccessThe prevalence change of hyperlipidemia and hyperglycemia and the effectiveness of yearly physical examinations: an eight-year study in Southwest China
The aim of this study was to investigate the prevalence changes of hyperlipidemia and hyperglycemia from 2009 to 2016 and the effectiveness of yearly physical examinations to hyperlipidemia and hyperglycemia prevention in Chengdu. A total of 794 residents (499 males) who have undergone annual health check-ups for 8 consecutive years (from 2009 to 2016) in Chengdu, a city in southwest China were selected as the follow-up group, 7226 residents in 2009 and 75,068 residents in 2016 who underwent health examinations in the same hospital were chosen to be the contemporary control group. The concentration of fasting serum triglyceride(TG), total cholesterol(TC), low density lipoprotein cholesterol(LDL-C), high density lipoprotein cholesterol (HDL-C) and glucose were measured and compared among these groups. There was a clear rise in the prevalence of hypercholesterolemia and hyperglycemia from 2009 to 2016 (p < 0.05). The follow-up group didn’t show difference in levels of serum lipids and glucose compared with the general population after an 8-years’ consecutive physical examination (p > 0.05), the follow-up cohort in the 8th year exhibited significant increases in serum total cholesterol and glucose compared with the 1st year (p < 0.05). The prevalence of hypercholesterolemia and hyperglycemia were increased significantly from 2009 to 2016. Annual physical examination didn’t show a positive effect in the prevention of hypercholesterolemia and hyperglycemia. Health education should be improved to ensure the fulfillment of the preventive objective of yearly physical examination.
- 1 September 2015
- Vol. 46 (5) , 750-3
[Association of Serum Uric Acid with 2-hour Postload Glucose in Predibetic Patients].
To investigate whether serum uric acid (SUA) is associated with 2-hour postload glucose (2-h PG) in predibetic patients. There were 3 588 subjects enrolled in this study from May 2014 to March 2015 in the department of physical examination center and outpatient clinic of West China Hospital of Sichuan University. All the subjects received a 75-g oral glucose tolerance test (OGTT) and measurements of serum uric acid (SUA), Creatinine, Cystatin (Cys-C), serum lipid and glycosylated hemoglobin (HbAlc). According to the results of glucose and HbAlc, the subjects were divided into three groups, including normal glucose regulation (NGT), impaired glucose regulation (IGR) and Type 2 Diabetes Mellitus (T2DM) group. The correlation between 2-h PG and serum uric acid in each group was analyzed. Based on the exam results, there were 556 cases of NGT, 1 019 cases of IGR, 2 013 cases of T2DM. There were statistically significant differences of glucose, serum insulin, triglycerides, high density lipoprotein, HbAlc, SUA, Creatinine, Cys-C levels among the three groups (P<0. 05). Multiple linear regression analysis showed that SUA level was positively correlated to 2-h PG level (P<0. 05) in NGT and IGR groups, but there was no correlation in T2DM group (P=0. 156). In the entire study population, levels of HbAlc and FPG were positive to 2-h PG correlated (P<0. 05). Positive correlation existed between FPG and 2-h PG in NGT group (P=0. 031). In IGR and T2DM group, HbAlc and 2-h PG were positively correlated (P<0. 05). HbAlc, FPG and SUA levels were independent risk factors for 2-h PG. In prediabetes, 2-h PG is associated with SUA and independent of FPG, HbAlc and other known risk factors. SUA may play a key role in the prediabetic condition as a risk indicator of T2DM.
- 1 September 2015
- Vol. 46 (5) , 750-3
[Association of Serum Uric Acid with 2-hour Postload Glucose in Predibetic Patients].
To investigate whether serum uric acid (SUA) is associated with 2-hour postload glucose (2-h PG) in predibetic patients. There were 3 588 subjects enrolled in this study from May 2014 to March 2015 in the department of physical examination center and outpatient clinic of West China Hospital of Sichuan University. All the subjects received a 75-g oral glucose tolerance test (OGTT) and measurements of serum uric acid (SUA), Creatinine, Cystatin (Cys-C), serum lipid and glycosylated hemoglobin (HbAlc). According to the results of glucose and HbAlc, the subjects were divided into three groups, including normal glucose regulation (NGT), impaired glucose regulation (IGR) and Type 2 Diabetes Mellitus (T2DM) group. The correlation between 2-h PG and serum uric acid in each group was analyzed. Based on the exam results, there were 556 cases of NGT, 1 019 cases of IGR, 2 013 cases of T2DM. There were statistically significant differences of glucose, serum insulin, triglycerides, high density lipoprotein, HbAlc, SUA, Creatinine, Cys-C levels among the three groups (P<0. 05). Multiple linear regression analysis showed that SUA level was positively correlated to 2-h PG level (P<0. 05) in NGT and IGR groups, but there was no correlation in T2DM group (P=0. 156). In the entire study population, levels of HbAlc and FPG were positive to 2-h PG correlated (P<0. 05). Positive correlation existed between FPG and 2-h PG in NGT group (P=0. 031). In IGR and T2DM group, HbAlc and 2-h PG were positively correlated (P<0. 05). HbAlc, FPG and SUA levels were independent risk factors for 2-h PG. In prediabetes, 2-h PG is associated with SUA and independent of FPG, HbAlc and other known risk factors. SUA may play a key role in the prediabetic condition as a risk indicator of T2DM.
- 26 October 2014
- Published by Springer Nature in Tumor Biology
- Vol. 36 (2) , 1245-1250
Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma
Wnt/β-catenin signaling pathway, having a crucial role in regulating diverse cellular processes, can be a new therapeutic target in cancer. To investigate the role of Dkk-1 (Dickkopf-1) and Dkk-3 in tumors and cirrhoses of the liver tissue in hepatocellular carcinoma (HCC), tissues from 38 patients with HCC resections including 5 patients who underwent hemangioma surgery of adjacent tumor tissues at the same time were obtained. Tissues were divided into three groups (nonfibrosis, cirrhosis, and carcinoma) through hematoxylin-eosin (HE) staining. Methylation-specific polymerase chain reaction (PCR) (MSP) measured the methylation status, and reverse transcription-PCR tested the messenger RNA (mRNA) levels, and immunohistochemical analysis provided levels of protein expression. The methylation detection rate of Dkk-1 and Dkk-3 was the highest (P < 0.05) and the mRNA levels of Dkk-1 and Dkk-3 were the lowest (P < 0.05) in the carcinoma tissues. The mRNA levels of β-catenin were significantly higher in the carcinoma tissue than the other tissues (P < 0.05). The expression of Dkk-1 and Dkk-3 was significantly higher in the carcinoma tissues than the other tissues (P < 0.05); but the β-catenin expression was the highest (P < 0.05). Compared with the control, the mRNA levels of β-catenin in the Dkk-1 and Dkk-3 silencing cells increased 5.34 (P < 0.05) and 3.5 times (P > 0.05). After the interference of 5-aza-2′-deoxycytidine, the mRNA levels of Dkk-1 and Dkk-3 significantly increased 58.9 and 59.3 times (P < 0.0001), and the mRNA levels of β-catenin decreased 6.02 times (P < 0.05). In the process of HCC, the abnormal activity of Wnt/β-catenin signaling may be associated with the methylation of Dkk-1 and Dkk-3.
- 26 October 2014
- Published by Springer Nature in Tumor Biology
- Vol. 36 (2) , 1245-1250
Preliminary mechanism on the methylation modification of Dkk-1 and Dkk-3 in hepatocellular carcinoma
Wnt/β-catenin signaling pathway, having a crucial role in regulating diverse cellular processes, can be a new therapeutic target in cancer. To investigate the role of Dkk-1 (Dickkopf-1) and Dkk-3 in tumors and cirrhoses of the liver tissue in hepatocellular carcinoma (HCC), tissues from 38 patients with HCC resections including 5 patients who underwent hemangioma surgery of adjacent tumor tissues at the same time were obtained. Tissues were divided into three groups (nonfibrosis, cirrhosis, and carcinoma) through hematoxylin-eosin (HE) staining. Methylation-specific polymerase chain reaction (PCR) (MSP) measured the methylation status, and reverse transcription-PCR tested the messenger RNA (mRNA) levels, and immunohistochemical analysis provided levels of protein expression. The methylation detection rate of Dkk-1 and Dkk-3 was the highest (P < 0.05) and the mRNA levels of Dkk-1 and Dkk-3 were the lowest (P < 0.05) in the carcinoma tissues. The mRNA levels of β-catenin were significantly higher in the carcinoma tissue than the other tissues (P < 0.05). The expression of Dkk-1 and Dkk-3 was significantly higher in the carcinoma tissues than the other tissues (P < 0.05); but the β-catenin expression was the highest (P < 0.05). Compared with the control, the mRNA levels of β-catenin in the Dkk-1 and Dkk-3 silencing cells increased 5.34 (P < 0.05) and 3.5 times (P > 0.05). After the interference of 5-aza-2′-deoxycytidine, the mRNA levels of Dkk-1 and Dkk-3 significantly increased 58.9 and 59.3 times (P < 0.0001), and the mRNA levels of β-catenin decreased 6.02 times (P < 0.05). In the process of HCC, the abnormal activity of Wnt/β-catenin signaling may be associated with the methylation of Dkk-1 and Dkk-3.
- 1 March 2014
- Vol. 45 (2) , 274-7, 298
[Study of glycated albumin cut-off point in diabetes mellitus and impaired glucose regulation].
To investigate the cut-off point of glycated albumin (GA) in the detection of diabetes mellitus (DM) and impaired glucose regulation (IGR). This study was conducted in 20-84 years-old adults who had risk factors of diabetes but no previously diagnosed diabetes. There were finally 392 individuals included and received the measurement of GA and HbA1c. Receiver operating characteristic curve (ROC) was plotted to determine the performance of GA. (1) Based on the diabetes diagnosis criteria of WHO (1999), the subjects were divided into DM group (n = 131), IGR group (n = 126), and normal glucose tolerance (NGT) group (n = 135). The GA level in the three groups tended to increase (P < 0.05). (2) Spearman correlation analysis demonstrated that GA was positively correlated with glycated haemoglobin A1c (HbA1c) (r = 0.942 1, P < 0.05), fasting plasma glucose (FPG) (r = 0.856 6, P < 0.05) and 2 h post-load plasma glucose (2-hPG) (r = 0.813 7, P < 0.05). (3) The mean levels of serum GA/HbA1c were 2.58 +/- 0.37, 2.44 +/- 0.37 and 2.17 +/- 0.25 for DM, IGR and NGT respectively. (4) The optimal cut-off points for detecting diabetes were 16.6% in GA [area under the carve (AUC) = 0.888], producing the sensitivity of 71.8% and the specificity of 87.4%. GA as a single screening test shows adequate to detect newly diagnosed DM, and the optimal GA cut-off point was 16.6% in this study.
- 1 March 2014
- Vol. 45 (2) , 274-7, 298
[Study of glycated albumin cut-off point in diabetes mellitus and impaired glucose regulation].
To investigate the cut-off point of glycated albumin (GA) in the detection of diabetes mellitus (DM) and impaired glucose regulation (IGR). This study was conducted in 20-84 years-old adults who had risk factors of diabetes but no previously diagnosed diabetes. There were finally 392 individuals included and received the measurement of GA and HbA1c. Receiver operating characteristic curve (ROC) was plotted to determine the performance of GA. (1) Based on the diabetes diagnosis criteria of WHO (1999), the subjects were divided into DM group (n = 131), IGR group (n = 126), and normal glucose tolerance (NGT) group (n = 135). The GA level in the three groups tended to increase (P < 0.05). (2) Spearman correlation analysis demonstrated that GA was positively correlated with glycated haemoglobin A1c (HbA1c) (r = 0.942 1, P < 0.05), fasting plasma glucose (FPG) (r = 0.856 6, P < 0.05) and 2 h post-load plasma glucose (2-hPG) (r = 0.813 7, P < 0.05). (3) The mean levels of serum GA/HbA1c were 2.58 +/- 0.37, 2.44 +/- 0.37 and 2.17 +/- 0.25 for DM, IGR and NGT respectively. (4) The optimal cut-off points for detecting diabetes were 16.6% in GA [area under the carve (AUC) = 0.888], producing the sensitivity of 71.8% and the specificity of 87.4%. GA as a single screening test shows adequate to detect newly diagnosed DM, and the optimal GA cut-off point was 16.6% in this study.